Skip to content

LONA LONA Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
Erasca, Inc. logo
Erasca, Inc.ERAS
Immunome logo
ImmunomeIMNM
Arcus Biosciences logo
Arcus BiosciencesRCUS

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's deferred tax assets and other non-current assets?
LONA (LONA) reported deferred tax assets and other non-current assets of $55K in Q1 2026.
How has LONA's deferred tax assets and other non-current assets changed year-over-year?
LONA's deferred tax assets and other non-current assets decreased by 35.3% year-over-year, from $85K to $55K.
What is the long-term trend for LONA's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), LONA's deferred tax assets and other non-current assets has grown at a -16.1% compound annual growth rate (CAGR), from $132K to $55K.